Literature DB >> 12578828

Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability.

Julio C Morales1, Zhenfang Xia, Tao Lu, Melissa B Aldrich, Bin Wang, Corina Rosales, Rodney E Kellems, Walter N Hittelman, Stephen J Elledge, Phillip B Carpenter.   

Abstract

p53-binding protein-1 (53BP1) is phosphorylated in response to DNA damage and rapidly relocalizes to presumptive sites of DNA damage along with Mre11 and the phosphorylated histone 2A variant, gamma-H2AX. 53BP1 associates with the BRCA1 tumor suppressor, and knock-down experiments with small interfering RNA have revealed a role for the protein in the checkpoint response to DNA damage. By generating mice defective in m53BP1 (m53BP1(tr/tr)), we have created an animal model to further explore its biochemical and genetic roles in vivo. We find that m53BP1(tr/tr) animals are growth-retarded and show various immune deficiencies including a specific reduction in thymus size and T cell count. Consistent with a role in responding to DNA damage, we find that m53BP1(tr/tr) mice are sensitive to ionizing radiation (gamma-IR), and cells from these animals exhibit chromosomal abnormalities consistent with defects in DNA repair. Thus, 53BP1 is a critical element in the DNA damage response and plays an integral role in maintaining genomic stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578828     DOI: 10.1074/jbc.M212484200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Authors:  Atsushi Shibata; Olivia Barton; Angela T Noon; Kirsten Dahm; Dorothee Deckbar; Aaron A Goodarzi; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

2.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

3.  Histone modification-dependent and -independent pathways for recruitment of checkpoint protein Crb2 to double-strand breaks.

Authors:  Li-Lin Du; Toru M Nakamura; Paul Russell
Journal:  Genes Dev       Date:  2006-06-15       Impact factor: 11.361

Review 4.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

Review 5.  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Authors:  Arun Gupta; Clayton R Hunt; Sharmistha Chakraborty; Raj K Pandita; John Yordy; Deepti B Ramnarain; Nobuo Horikoshi; Tej K Pandita
Journal:  Radiat Res       Date:  2013-12-09       Impact factor: 2.841

6.  Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage.

Authors:  Yoonsung Kang; Jung-Hee Lee; Nguyen Ngoc Hoan; Hong-Moon Sohn; In-Youb Chang; Ho Jin You
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

7.  Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells.

Authors:  Monica Croke; Martin A Neumann; David A Grotsky; Ray Kreienkamp; Sree C Yaddanapudi; Susana Gonzalo
Journal:  Cell Cycle       Date:  2013-10-02       Impact factor: 4.534

8.  Phosphorylation-dependent interactions of BLM and 53BP1 are required for their anti-recombinogenic roles during homologous recombination.

Authors:  Vivek Tripathi; Sarabpreet Kaur; Sagar Sengupta
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

9.  53BP1 promotes ATM activity through direct interactions with the MRN complex.

Authors:  Ji-Hoon Lee; Aaron A Goodarzi; Penny A Jeggo; Tanya T Paull
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

Review 10.  Mechanisms of double-strand break repair in somatic mammalian cells.

Authors:  Andrea J Hartlerode; Ralph Scully
Journal:  Biochem J       Date:  2009-09-25       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.